How supplements are actually regulated in Egypt

If you have never manufactured in Egypt, the regulatory picture is usually presented to you as one thing: the National Food Safety Authority. That is the right place to start and a bad place to stop.

What follows is the shape of the system as it is actually experienced from inside a factory, including the parts that are administratively heavy. None of this is a substitute for the authority's own published requirements, and nothing here is legal advice.

The authority is younger than you think

Egypt's National Food Safety Authority (NFSA) was established in 2017, with its executive regulation issued in January 2018.

That date explains a great deal. A regulator less than ten years old is still building precedent, still issuing instruments that revise earlier ones, and still absorbing functions that previously sat elsewhere. The upside is a legible central framework where there used to be none — Egypt went from seven licensed supplement facilities in 2020 to 41 by 2025, which does not happen without one. The downside is that the ground moves more often than in a mature jurisdiction.

Dr. Mohamed Anwar, who chairs Organix and heads the Egyptian Association of Food and Dietary Supplement Manufacturers and Exporters, has described oversight of this sector as spread across a large number of separate bodies.

That spread of oversight is the most useful single thing to understand before you start, and there is no single published tally of it. Food safety is the central authority, but a supplement manufacturer in Egypt also deals, at various points, with industrial licensing and the industrial development authority, customs and import control, national standards, export documentation and export council bodies, chambers and industry federation structures, environmental and occupational safety oversight, and local municipal authorities.

Most of this is your manufacturer's problem, not yours. It becomes your problem in one specific way: it is why a document request that sounds trivial can take three weeks.

Two separate clearances, and people confuse them constantly

This is the single most expensive misunderstanding in Egyptian sourcing, so it is worth stating flatly.

The facility is cleared separately from the product.

A factory on the NFSA White List has been assessed and approved to manufacture. That listing says nothing about any individual product. We have written about exactly what it does and does not cover in the NFSA White List is a factory licence, not a product approval.

Your product then needs its own clearance. A listed facility cannot legally sell an uncleared product any more than an unlisted one can.

Two clearances, two owners, two timelines. The factory handles the first before you ever arrive. The second is a per-product file that begins when you do.

Notification and registration

The two words are used interchangeably in the trade, including by people who should be precise about it, which causes avoidable confusion.

What exists in practice for a dietary supplement is a per-product file: submitted for one product, made at one named facility, covering its composition, specifications, label and intended presentation. Whether your paperwork calls that a notification or a registration matters far less than three things about it.

Those three things, in order of how much they will cost you:

1. The file is specific. It is tied to a formula, a facility, a dosage form and a pack presentation. Change the formula, change the pack size, change the facility or change the claims, and you are amending or refiling rather than editing.
2. Clearance is not permission to advertise or export. Marketing claims and export documentation are governed separately. Treat them as their own tasks with their own lead times.
3. Someone holds the file, and it is not automatically you. Establish in writing whether the file stands in your name, your manufacturer's, or a local entity's. Whoever holds it controls your access to the market.

One boundary does change the framework entirely: a product whose composition or claims push it across the line into medicines is no longer a supplement file at all. Where that line sits is an administrative judgement rather than a scientific one, which is why claims should be settled before a file is drafted rather than after.

What the register size actually tells you

Registered supplement notifications in Egypt passed 11,000 in 2024 and 12,000 by 2025.

Dr. Anwar's estimate is that roughly half of those are actually marketed. The rest are filed and parked: brands that never launched, products held as placeholders, files kept alive for later.

Two things to take from that, both useful:

Your real competitor set is smaller than the register. Roughly half of that number is paperwork rather than product. A category that looks saturated on paper is usually being contested by a fraction of the brands the register implies.

Do not treat a notification as an asset. A cleared file that never reached a shelf cost somebody money and returned nothing. His own repeated advice to brand owners is the same: rather than filing five or ten notifications, file three and do them properly.

572, then 725

In 2022, ministerial decree 572 reshaped this market, and not gently.

Dr. Anwar's account is direct: the disruption was severe enough that a substantial part of the sector could have been stopped from operating, and the Egyptian Association of Food and Dietary Supplement Manufacturers and Exporters was formed in response to it — in his words, born in the womb of that suffering. A later instrument, decree 725, brought a further round of adjustment, and he has said plainly that his own factory was affected by it.

The association's function in that period was defensive: supporting companies, particularly small ones, through rule changes that threatened their ability to trade.

The point here is not political and we are not going to make it political. It is a planning observation, and it is the single most important thing a foreign brand owner should take from this article:

In this market, the regulatory framework can change inside a quarter, and the change can reach products already in production.

That has specific implications. Do not pre-print twelve months of artwork. Keep your files current rather than dormant. Put a clause in your manufacturing agreement covering who carries the cost when a rule change obsoletes packaging or a formula. Ask your manufacturer how they found out about the last significant change and what they did in the following month — the answer tells you whether they are connected to the sector or reading about it afterwards.

What a foreign brand owner should actually expect

The administrative load is real, and the burden mostly sits on the factory rather than on you. What you own is the input quality: a clear brief, final artwork, decided claims and a confirmed market. Vague inputs are the most common reason an Egyptian file sits still, and that delay gets reported to you as a regulatory delay because that is where it is visible.

For how all of this interacts with a launch calendar, see 45 to 90 days, and why your launch date is decided before that clock starts.

Before you start

• Decide your target market first. It determines the claims, which determine the file.
• Settle who holds the notification, in writing, before anything is submitted.
• Budget for clearance in months, in parallel with everything else, starting on day one.
• File fewer products properly rather than many speculatively.
• Ask your manufacturer which decrees have affected their operation in the last three years and how. A factory that cannot name them is not following the thing that will most affect your product.